Yoshikawa K - Search Results

1

Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen.

Ohno M, Natsume A, Ichiro Iwami K, Iwamizu H, Noritake K, Ito D, Toi Y, Ito M, Motomura K, Yoshida J, Yoshikawa K, Wakabayashi T. Ohno M, et al. Among authors: yoshikawa k. Cancer Sci. 2010 Dec;101(12):2518-24. doi: 10.1111/j.1349-7006.2010.01734.x. Epub 2010 Sep 30. Cancer Sci. 2010. PMID: 20880333 Free PMC article.

2

Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles.

Ito A, Shinkai M, Honda H, Yoshikawa K, Saga S, Wakabayashi T, Yoshida J, Kobayashi T. Ito A, et al. Among authors: yoshikawa k. Cancer Immunol Immunother. 2003 Feb;52(2):80-8. doi: 10.1007/s00262-002-0335-x. Epub 2003 Jan 29. Cancer Immunol Immunother. 2003. PMID: 12594571 Free PMC article.

3

Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.

Takasu S, Takahashi T, Okamoto S, Oriuchi N, Nakayashiki N, Okamoto K, Muramatsu H, Hayashi T, Nakahara N, Mizuno M, Wakabayashi T, Higuchi T, Endo K, Kozaki K, Miyaishi O, Saga S, Ueda R, Yoshida J, Yoshikawa K. Takasu S, et al. Among authors: yoshikawa k. J Neurooncol. 2003 Jul;63(3):247-56. doi: 10.1023/a:1024320516341. J Neurooncol. 2003. PMID: 12892230

4

Production and characterization of an active single-chain variable fragment antibody recognizing CD25.

Muramatsu H, Yoshikawa K, Hayashi T, Takasu S, Kawada Y, Uchida K, Sato S, Takahashi T, Saga S, Ueda R. Muramatsu H, et al. Among authors: yoshikawa k. Cancer Lett. 2005 Jul 28;225(2):225-36. doi: 10.1016/j.canlet.2004.12.018. Epub 2005 Jan 23. Cancer Lett. 2005. PMID: 15978327

5

[Antibody-based therapy for brain tumor].

Takasu S, Yoshikawa K, Yoshida J. Takasu S, et al. Among authors: yoshikawa k. Nihon Rinsho. 2005 Sep;63 Suppl 9:563-8. Nihon Rinsho. 2005. PMID: 16201582 Review. Japanese. No abstract available.

6

Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.

Araki Y, Yoshikawa K, Okamoto S, Sumitomo M, Maruwaka M, Wakabayashi T. Araki Y, et al. Among authors: yoshikawa k. BMC Neurol. 2010 Nov 8;10:112. doi: 10.1186/1471-2377-10-112. BMC Neurol. 2010. PMID: 21059247 Free PMC article.

7

Biomarker research for moyamoya disease in cerebrospinal fluid using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Maruwaka M, Yoshikawa K, Okamoto S, Araki Y, Sumitomo M, Kawamura A, Yokoyama K, Wakabayashi T. Maruwaka M, et al. Among authors: yoshikawa k. J Stroke Cerebrovasc Dis. 2015 Jan;24(1):104-11. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.028. Epub 2014 Oct 28. J Stroke Cerebrovasc Dis. 2015. PMID: 25440344

8

Elevation of Proenkephalin 143-183 in Cerebrospinal Fluid in Moyamoya Disease.

Yokoyama K, Maruwaka M, Yoshikawa K, Araki Y, Okamoto S, Sumitomo M, Kawamura A, Sakamoto Y, Shimizu K, Izumi T, Wakabayashi T. Yokoyama K, et al. Among authors: yoshikawa k. World Neurosurg. 2018 Jan;109:e446-e459. doi: 10.1016/j.wneu.2017.09.204. Epub 2017 Oct 13. World Neurosurg. 2018. PMID: 29030229

9

Immune-checkpoint molecules on regulatory T-cells as a potential therapeutic target in head and neck squamous cell cancers.

Suzuki S, Ogawa T, Sano R, Takahara T, Inukai D, Akira S, Tsuchida H, Yoshikawa K, Ueda R, Tsuzuki T. Suzuki S, et al. Among authors: yoshikawa k. Cancer Sci. 2020 Jun;111(6):1943-1957. doi: 10.1111/cas.14422. Epub 2020 May 19. Cancer Sci. 2020. PMID: 32304268 Free PMC article.

10

T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinoma.

Harada M, Iida Y, Kotani H, Minami T, Komohara Y, Eto M, Yoshikawa K, Uemura H. Harada M, et al. Among authors: yoshikawa k. Cancer Immunol Immunother. 2022 Feb;71(2):339-352. doi: 10.1007/s00262-021-02992-7. Epub 2021 Jun 23. Cancer Immunol Immunother. 2022. PMID: 34160685 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,720 results

Search Page